Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment

Heart

Volumn 76, Issue 3, 1996, Pages 232-237

  Omland, Torbjørn ^a,c   Aakvaag, Asbjørn ^a   Vik Mo, Harald ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brain natriuretic peptide; Chronic heart failure; Left ventricular function; N terminal pro atrial natriuretic factor

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0029783064     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.3.232     Document Type: Article

References (34)

1. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327: 669-77.
2. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
3. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325: 293-302.
4. The SOLVD investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
5. McDonagh T, Morrison C, McMurray JJ, Duncan D, Ford I, Tunstall-Pedoe H, et al. The prevalence of left ventricular dysfunction in north Glasgow (abstract). Circulation 1994;90:1-282.
6. Remes J, Miettinen H, Reuanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21.
7. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang C, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9.
8. Rouleau JL, deChamplain J, Klein M, Bichet D, Moyé LA, Packer M, et al. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol 1993;22:390-8.
9. Benedict CR, Johnstone DE, Weiner DH, Bourassa MG, Bittner V, Kay R, et al. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1994;23: 1410-20.
10. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9.
11. Wei CH, Heublein DM, Perella MA, Lerman A, Rodeheffer RJ, McGregor CGA, et al. Natriuretic peptide system in human heart failure. Circulation 1993; 88:1004-9.
12. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction. Lancet 1993;341:1109-13.
13. Raine AEG, Eme P, Bürgisser E, Müller FB, Bolli P, Burkhart F, et al, Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986;315:533-7.
14. Mathisen P, Hall C, Simonsen S. Comparative studies of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease. Scand J Clin Lab Invest 1993;53:41-9.
15. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87:464-9.
16. Richards AM, Crozier IG, Yandle TG, Espiner EA, Ikram H, Nicholls MG. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 1993;69:414-7.
17. Haug C, Metzele A, Kochs M, Hombach V, Grünert A. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular enddiastolic pressure. Clin Cardiol 1993;16:553-7.
18. Choy AMJ, Darbar D, Lang CC, Pringle TH, McNeill GP, Kennedy NSJ, et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 1994;72:16-22.
19. Struthers AD. Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? Br Med J 1994;308:1615-9.
20. Davidson NC, Coutie WJ, Struthers AD. N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro. Circulation 1995;91:1276 (letter).
21. Hall C, Aaberge L, Stokke O. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation 1995;91:911 (letter).
22. Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968;75:325-34.
23. Omland T, Bonarjee VVS, Aakvaag A, Aarsland T, Dickstein K. The relationship between early plasma atrial natriuretic factor levels and exercise performance after myocardial infarction. Eur Heart J 1993;14:1022-6.
24. Kettunen RVJ, Leppäluoto J, Jounela A, Vuolteenaho O. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction. Am Heart J 1994;127:1449-55.
25. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993;76:832-8.
26. DeLeo JM. Receiver operating characteristic laboratory (ROCLAB): software for developing decision strategies that account for uncertainty. Proceedings of the Second International Symposium on Uncertainty Modeling and Analysis. Los Alamitos, California: IEEE Computer Society Press, 1993:318-25.
27. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
28. Caidahl K, Hedner J, Hedner T. Atrial natriuretic peptide and catecholamines in peripheral blood as indicators of cardiac dysfunction in the general population. Clin Sci 1988;74:587-94.
29. Wallé T, Landahl S, Hedner T, Hedner J, Hall C. Atrial peptides, ANP (1-98) and ANP (99-126) in health and disease in an elderly population. Eur Heart J 1993;14: 1508-13.
30. Hall C, Rouleau JL, Moyé LA, de Champlain J, Bichet D, Klein M, et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation 1994;89:1934-42.
31. Omland T, Aarsland T, Aakvaag A, Lie RT, Dickstein K. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am J Cardiol 1993;72:255-9.
32. Omland T, Bonarjee VVS, Nilsen DWT, Sundsfjord JA, Lie RT, Thibault G, et al. Prognostic significance of Nterminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. Br Heart J 1993; 70:409-14.
33. Rouleau JL, Packer M, Moyé LA, de Champlain J, Bichet D, Klein M, et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 1994; 24:583-91.
34. Arakawa N, Nakamura M, Aoki H, Moriai N, Suzuki T, Hiramori K. Prognostic value of plasma brain natriuretic peptide concentration in patients with acute myocardial infarction (abstract). Circulation 1994;90:I-279.